Mingyue Xiao
Jiayi Liang
Jie Ren- Department of Ultrasound, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
Ectopic spleen (ES) is a rare condition. It is difficult to diagnose with conventional imaging modalities. In this case series, we presented the imaging features of three misdiagnosed ES cases in our hospital and previously reported cases to compare the consistency of enhancement patterns among different imaging modalities with varied phases. Finally, 22 cases were reviewed. We determined that variable arterial phase enhancement and persistent enhancement throughout the portal and delayed phases are present in contrast-enhanced ultrasound (CEUS) imaging of the ES and found the arterial phase of CEUS had the highest consistency compared with computerized tomography (CT) and magnetic resonance imaging (MRI).
1 Introduction
Ectopic spleen (ES), which results from the autotransplantation of splenic tissue and often occurs after splenectomy, may be divided into two categories, namely, accessory spleens and wandering spleen, which are congenital foci of healthy splenic tissue that are distinct from the main body of the spleen (1, 2). Ectopic spleens usually present as asymptomatic conditions that may not require surgical resection. However, some ES may present as abdominal emergency and require medical intervention (3). The clinical symptoms of ES are usually nonspecific and related to the compression of another organ and torsion of the pedicle.
There is no definitive characterization by any imaging method (4). Therefore, the nonspecific clinical and imaging presentation makes the differential diagnosis of ES extremely challenging, and the final diagnosis is largely dependent on the pathological examination. In addition to the symptoms caused by ES itself requiring treatment, the overtreatment caused by misdiagnosis should not be ignored. Therefore, an accurate diagnosis of ES is crucial to its management.
It has recently been demonstrated that contrast-enhanced ultrasound (CEUS), which is employed in a variety of clinical situations, is useful for characterizing localized lesions (5, 6). Using the high accuracy of microbubble contrast agents, the blood flow around and inside the lesion was clearly visualized. The advantage of CEUS was especially useful in diagnosing liver lesions. In order to characterize ambiguous results of localized liver lesions after computed tomography (CT) and magnetic resonance imaging (MRI) scans, the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) has advocated using CEUS within its recommendations (5).
Therefore, we conducted this case series and literature reviews to summarize the ES imaging features of CT, MRI, and CEUS. Moreover, we tried to explore which imaging modality had the highest diagnostic consistency.
2 Case presentations
Case 1 was a 34-year-old woman without a history of splenectomy or trauma. She had no clinical manifestations other than fatigue and weight gain. Conventional ultrasound (US) revealed a hypoechoic circular lesion in the tail of the pancreas, approximately 2.2 cm in size, with uniform internal echogenicity and clear borders, which means that no obvious Echo alteration can be observed and to distinguish the lesion with surrounding tissue is difficult (Figure 1A). CEUS suggested hyperenhancement in the arterial phase (Figure 1B) and mild hyperenhancement in the portal and delayed phases. There were three uniform solid masses with punctate blood flow signals seen in the liver, and CEUS showed equal or high enhancement in the arterial and portal phases and equal or low enhancement in the delayed phase. Enhanced CT suggested a round, isointense lesion in the tail of the pancreas (Figures 1C, D). MRI suggested a well-defined mass with low signal in the T1WI sequence and high signal in the T2WI sequence and a slight enhancement in the enhanced scan with late phase (Figures 1E, F). The patient also underwent positron emission computed tomography (PET) examination, and no obvious metabolic abnormality was found in the nodule of the pancreatic tail (Supplementary Figure S1). Based on the above data, the patient was diagnosed with pancreatic neuroendocrine tumor (PNET) with liver metastasis. Eventually, the patient subsequently underwent resection of the pancreatic and hepatic masses, splenectomy, and hepatic mass microwave ablation. Pathological results identified the lesion was ES.
Figure 1 Case 1 in our hospital. (A) Conventional two-dimensional ultrasonography revealed an ill-defined suborbicular lesion in the pancreatic tail (white row), with uneven hypoecho, of approximately 2.2 cm in size. (B) CEUS revealed hyperenhancement in the arterial phase. (C, D) Contrast-enhanced CT demonstrated a round iso-dense lesion (white rows) in the tail of the pancreas, with the mild enhancement in the arterial phase. (E) T2WI sequence revealed a well-defined round mass in the pancreatic tail, with high intensity. (F) Contrast-enhanced MRI showed slightly delayed enhancement (white row).
Case 2 was a 39-year-old man who had a splenectomy 16 years ago. He experienced no clinical symptoms. US suggested a slightly hyperechoic round mass in segment II of the liver measuring approximately 1.9 cm in size with even internal echogenicity and clear borders (Figure 2A). CEUS suggested high enhancement in the arterial, portal, and delayed phases (Figure 2B). MRI examination suggested that the mass showed low T1 signal intensity and low T2 signals (Figures 2C–E). Magnetic resonance diffusion-weighted imaging (DWI) showed no restricted diffusion in the mass (Figure 2F). Based on the above imaging findings, it is suspected of atypical vasoproliferative tumor of the liver or focal nodular hyperplasia (FNH). Subsequently, laparoscopic resection of the tumor located in liver segment II was performed. Pathological results identified that the lesion was ES.
Figure 2 Case 2 in our hospital. (A) US demonstrated a round mass in the segment II of the liver near the dome of the diaphragm, with even slightly hyperecho, measuring about 1.9 cm ×1.6 cm. (B) CEUS was performed and revealed hyperenhancement in the delayed phase (white rows). (C) The mass in the segment II of the liver (white rows) revealed low T2 signal. (D, E) Enhanced MR showed an arterial enhancement and had a gradual washout in the venous phases. (F) On DWI, no restricted diffusion was shown in the mass.
Case 3 was a 57-year-old man with a history of chronic hepatitis B cirrhosis. He had three hepatocellular carcinoma ablations and splenectomy 4 years prior with no clinical symptoms. Two-dimensional US showed an isoechoic and round-like mass in segment II of the liver, approximately 1.9 cm in size. The boundary was unclear, and the internal echo was even. CEUS suggested hyperenhancement in the arterial phase and iso-enhancement in the portal and delayed phases (Figures 3A, B). MRI and the enhancement scan are shown in Figures 3C, D.
Figure 3 Case 3 in our hospital. (A) CEUS suggested iso-enhancement in the portal phase (white rows). (B) Routine two-dimensional US showed an iso-echoic and round-like mass in the segment II of the liver. (C, D) The lesion (white rows) showed short T2 signal, and the enhancement scan suggested gradual signal attenuation after 5 min in the delayed phase.
The baseline and imaging data for the three cases are shown in Table 1, and the pathological presentations are detailed in Supplementary Figures S2-S4. Pathological results identified that the lesion was ES.
Table 1 The basic characteristics of three patients with ectopic spleens.
3 Case summaries from previous studies
After the databases were searched, the data for 22 cases who underwent CT, MRI, and CEUS from 17 case reports were obtained (7–23). In total, 25 cases were included for further analysis. The summary of the baseline characteristics of the 25 cases is presented in Table 2. Of the patients, 83.3% of them were men, with a median age of 53 years (ranging from 10 to 70 years); 75% (12/16) had a history of splenectomy, and one case had splenic trauma. The sizes of the lesions ranged from 0.5 cm to 7 cm and were unknown in one case; the median tumor size was 2.1 cm. Most (22/25, 88%) of the lesions were single and often located in the pancreatic tail (48%, 12/25), the liver (20%, 5/25), the intraperitoneum, or the abdominal cavity organs (16%, 4/25), and so on.
Table 2 Baselines characteristics of the 25 cases with ectopic spleen.
3.1 The presentations of CT and MRI
The most common presentations of enhanced CT in the arterial phase were homogeneous high enhancement (10/19; 52.6%), followed by inhomogeneous high enhancement (6/19; 31.6%). On portal and late phases, the most common findings of masses were homogeneous high enhancement (66.7%, 12/18) (Table 3). On the arterial phase, the most common presentations of MRI scans were homogeneous high enhancement (8/15; 53.3%), followed by inhomogeneous high enhancement (4/15; 26.7%) (Table 3).
Table 3 CT and MRI presentations of the 25 cases with ectopic spleen.
3.2 The presentations of CEUS
Compared with the surrounding normal tissue, 91% (20/22) of the lesions showed hyperenhancement in the arterial phase. Most of the lesions showed varying degrees of hyperenhancement in the portal phase and delayed phase, respectively. In the delayed phase, only three cases showed iso-enhancement or obvious washout (hypoenhancement). A total of 11 cases described the degree of enhancement of the lesion compared with the splenic parenchyma, all of which presented equal enhancement at different phases, showing a similar enhancement pattern to that of the spleen (Table 4).
Table 4 Contrast-enhanced ultrasonography presentations of the 25 cases with ectopic spleen.
3.3 Comparison results of different imaging modalities
On the arterial phase, the enhancement patterns of lesions in CEUS (91%) presentations had higher consistency than CT (52.6%) and MRI (53.3%), and the differences were significantly different (p = 0.017 and 0.012). On portal phase, the enhancement patterns in CEUS (91%) presentations had higher consistency than CT (66.6%) and MRI (73.3%), but the differences were not significantly different (p = 0.10 and 0.198). Similarly, on the delayed phase, the enhancement patterns in CEUS (87%) presentations had higher consistency than CT (66.6%) and MRI (73.3%), but the differences were not significantly different (p = 0.147 and 0.401, respectively).
4 Discussion
ES is rare in clinical practice. It usually relates to spleen trauma or splenectomy, which could cause the direct spread of splenic tissue fragments. It might also occur along the splenic vessels, in the splenorenal or gastrosplenic ligaments, the greater omentum or the mesentery, the wall of the stomach or bowel, and in the pelvis or scrotum (24). ES usually involves multiple lesions, ranging in diameter from a few millimeters to 7 cm and even >12 cm (25). It is impossible to perform surgical exploration in every single patient; therefore, imaging examinations are still the first choice in diagnosing ES. The ability to diagnose ES is crucial for avoiding unnecessary surgery. The variable morphology and clinical manifestations made it difficult to diagnose.
As a result of the varying flowrates of the cord and sinuses in the red pulp, CT or MRI of a normal spleen may show a mottled pattern of enhancement in the arterial phase and early portal venous phase (26, 27). However, the implanted splenic tissue lacks the usual splenic vascular pattern, and the blood supply pattern is different. In addition to our three cases, other rare case reports demonstrate that ectopic spleen is usually misdiagnosed as a malignant or benign hypervascular neoplasm with nonspecific imaging features on US, CT, or MRI (14–16). In our study, CT and MRI had a diagnostic consistency of 50%–70% in diagnosing ES; therefore, sometimes CT and MRI are not reliable.
CEUS, a safe, nonradiative, relatively inexpensive, and convenient imaging modality, can provide useful evidence for clinical diagnosis. CEUS applications have gained increasing experience in the differential diagnosis of space-occupying lesions in recent years. Numerous national and international groups have advocated the use of the CEUS test for the diagnosis of focal liver lesions (28). Referring to the CEUS performance of ES, it is rarely reported in the literature.
According to reports, SonoVue is a pure blood pool contrast agent, meaning that after injection, the microbubbles only temporarily stay in the blood vessel. A pharmacological kinetics study showed that the intake of the contrast agent in the right hepatic lobe and both kidneys declined from 88% to 67% within 5 min but that the spleen practically did not experience the same phenomenon (90%–99% intake) (29). Despite the fact that the mechanism behind how long the contrast microbubbles are kept in the spleen parenchyma or if they are also phagocytized by macrophages is yet unknown, SonoVue results in a spleen-specific enhancement that lasts for up to 5 min. This is distinctive and has a particular significance for the ES diagnosis.
Both benign and malignant neoplasms might exhibit hyperenhancement in the arterial phase. However, portal venous blood volume of malignant tumors is lower, which causes the contrast agent to wash out in the portal and/or late phases. As a result, for benign lesions, enhancement often continues until the late phase (29). Our study also identified that hyperenhancement in the portal or delayed phase was more common than arterial enhancement in CT and MRI presentations. Due to the small sample size, the statistical differences were not confirmed. However, we could still conclude that the hyperenhancement in the venous and delayed phase, a typical feature of most benign lesions, provides a clue for diagnosing ES, especially in patients who have undergone splenectomy or splenic trauma.
The three cases at our center showed the R2* value ranging from 225 to 275 in the IDEAL-IQ sequence, which is a quantitative indicator of iron deposition, indicating iron overload in our cases. Histology may provide evidence to support the theory that this is a result of splenic reticuloendothelial cells phagocytosing iron particles (30). Thus, lesions on T2WI sequences that exhibit equal or low signal intensity may aid in the confirmation of the diagnosis of ES. However, Berlin blue staining was not performed on all of the case reports included, and the feature should be validated in future studies.
In our study, we determined that variable arterial phase enhancement and persistent enhancement throughout the portal and delayed phases are present in CEUS imaging of the ES. We also identified that the consistency of enhancement patterns was higher in CEUS than CT or MRI, especially in the arterial phase. Our study may greatly benefit from the knowledge of CEUS in the management of ES.
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University. The studies were conducted in accordance with the local legislation and institutional requirements. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.
Author contributions
MX: Data curation, Writing – original draft. JL: Formal Analysis, Methodology, Writing – original draft. JR: Supervision, Writing – review & editing. RZ: Supervision, Writing – review & editing. LW: Supervision, Writing – review & editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. Funding details: Guangzhou Science and Technology Plan Project (Grant Number: 2023A03J0728).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fonc.2024.1310394/full#supplementary-material
References
1. Rajaram B, Venkanna M, Kumar DR, Kumaraswamy B, Reddy BS. Ectopic spleen presenting as lump abdomen: A rare case report and review of literature. J Clin Diagn Res. (2015) 9:PD26–7. doi: 10.7860/JCDR/2015/13135.6541
2. Rizzuto A, Di Saverio S. Laparoscopic splenectomy for a simultaneous wandering spleen along with an ectopic accessory spleen. Case report and review of the literature. Int J Surg Case Rep. (2018) 43:36–40. doi: 10.1016/j.ijscr.2018.01.017
3. King CR, Mansuria S. Pelvic pain in the presence of wandering spleen. J Minim Invasive Gynecol. (2013) 20:549–50. doi: 10.1016/j.jmig.2013.02.007
4. Rodríguez Vargas D, Parada Blázquez MJ, Vargas Serrano B. Diagnostic imaging of abnormalities in the number and location of the spleen. Radiologia (Engl Ed). (2019) 61:26–34. doi: 10.1016/j.rx.2018.07.002
5. Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (Long version). Ultraschall Med. (2018) 39:e2–e44. doi: 10.1055/a-0586-1107
6. Lerchbaumer MH, Kleemann T, Jung EM, Nagel S, Hamm B, Fischer T. Vascular pattern and diagnostic accuracy of contrast-enhanced ultrasound (CEUS) in spleen alterations. Clin Hemorheol Microcirc. (2020) 75:177–88. doi: 10.3233/CH-190758
7. Ota T, Ono S. Intrapancreatic accessory spleen: diagnosis using contrast enhanced ultrasound. Br J Radiol. (2004) 77:148–9. doi: 10.1259/bjr/56352047
8. Kim SH, Lee JM, Lee JY, Han JK, Choi BI. Contrast-enhanced sonography of intrapancreatic accessory spleen in six patients. AJR Am J Roentgenol. (2007) 188:422–8. doi: 10.2214/AJR.05.1252
9. Ota T, Masada T, Miyamoto Y, Yoshida A. A case of splenosis: diagnosis with contrast-enhanced ultrasonography. J Med Ultrason. (2001) 2005) 32:121–3. doi: 10.1007/s10396-005-0047-x
10. Ferraioli G, Di Sarno A, Coppola C, Giorgio A. Contrast-enhanced low-mechanical-index ultrasonography in hepatic splenosis. J Ultrasound Med. (2006) 25:133–6. doi: 10.7863/jum.2006.25.1.133
11. Rogers P, Williams MP, Fernando R, Freeman S. Pancreatic splenosis demonstrated by contrast-enhanced sonography. J Clin Ultrasound. (2011) 39:348–50. doi: 10.1002/jcu.20823
12. Makino Y, Imai Y, Fukuda K, Seki Y, Kogita S, Sawai Y, et al. Sonazoid-enhanced ultrasonography for the diagnosis of an intrapancreatic accessory spleen: a case report. J Clin Ultrasound. (2011) 39:344–7. doi: 10.1002/jcu.20798
13. De Robertis R, D'Onofrio M, Manfrin E, Dal Bo C, Pozzi Mucelli R. A rare case of pancreatic head splenosis diagnosed by contrast-enhanced ultrasound. Ultraschall Med. (2014) 35:72–4. doi: 10.1055/s-0033-1335136
14. Marques S, Bispo M, Noia L. Intrapancreatic accessory spleen: A diagnosis not to forget! Case Rep Gastroenterol. (2016) 10:749–54. doi: 10.1159/000452760
15. Kruger R, Freeman S. An unusual pelvic mass: Contrast-enhanced sonographic diagnosis of pelvic splenosis. J Clin Ultrasound. (2019) 47:172–4. doi: 10.1002/jcu.22671
16. Sansone V, Falsetti L, Tovoli F, Golfieri R, Cescon M, Piscaglia F. An uncommon focal liver lesion: intrahepatic splenosis. J Gastrointestin Liver Dis. (2020) 29:257–62. doi: 10.15403/jgld-617
17. Luo J, Chen J, Huang F, Zhou P, Huang P. Heterotopic accessory spleen with squamous epithelial cyst in pancreas mimicking other pancreatic tumor: a case report. Ann Transl Med. (2020) 8:507. doi: 10.21037/atm.2020.03.79
18. Dölle M, Ringe KI, Hartleben B, Braubach P, Thol F, Gebel M, et al. A supposed hepatocellular adenoma turns out to be intrahepatic splenosis - a case report. Z Gastroenterol. (2021) 59:149–52. doi: 10.1055/a-1340-0498
19. Zhong X, Yang L, Huang J, Deng L, Nie L, Lu Q. Contrast-enhanced ultrasonographic imaging of hepatic splenosis: A case report. Med (Baltimore). (2021) 100:e24243. doi: 10.1097/MD.0000000000024243
20. Yankov I, Boyanov N. Intrapancreatic accessory spleen in child. Turk J Pediatr. (2022) 64:599–603. doi: 10.24953/turkjped.2021.4932
21. Föh B, Sieren MM, Both M, Seeger M, Günther R. Extensive intrathoracic and intraperitoneal splenosis mimicking mesothelioma: a case report. J Med Case Rep. (2022) 16:73. doi: 10.1186/s13256-022-03288-9
22. Kroenig J, Safai Zadeh E, Westhoff CC, Klemmer A, Alhyari A, Görg C. Diagnosis of thoracic splenosis by contrast-enhanced ultrasound (CEUS). Ultraschall Med. (2023) 44:645–6. doi: 10.1055/a-1926-7142
23. Liu W, Chen S, Chen J, Jiang T, Quan L, Xie S. Application of multimodal imaging in the diagnosis of intrahepatic splenosis: Two case reports and a literature review. BJR Case Rep. (2022) 8:20210170. doi: 10.1259/bjrcr.20210170
24. Varga I, Galfiova P, Adamkov M, Danisovic L, Polak S, Kubikova E, et al. Congenital anomalies of the spleen from an embryological point of view. Med Sci Monit. (2009) 15:RA269–76.
25. Gruen DR, Gollub MJ. Intrahepatic splenosis mimicking hepatic adenoma. AJR Am J Roentgenol. (1997) 168:725–6. doi: 10.2214/ajr.168.3.9057523
26. Abbott RM, Levy AD, Aguilera NS, Gorospe L, Thompson WM. From the archives of the AFIP: primary vascular neoplasms of the spleen: radiologic-pathologic correlation. Radiographics. (2004) 24:1137–63. doi: 10.1148/rg.244045006
27. Tsitouridis I, Michaelides M, Sotiriadis C, Arvaniti M. CT and MRI of intraperitoneal splenosis. Diagn Interv Radiol. (2010) 16:145–9. doi: 10.4261/1305-3825
28. Dong Y, Mao F, Cao J, Fan P, Wang WP. Characterization of focal liver lesions indistinctive on B mode ultrasound: benefits of contrast-enhanced ultrasound. BioMed Res Int. (2017) 2017:8970156. doi: 10.1155/2017/8970156
29. Lim AK, Patel N, Eckersley RJ, Taylor-Robinson SD, Cosgrove DO, Blomley MJ. Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers. Radiology. (2004) 231:785–8. doi: 10.1148/radiol.2313030544
Keywords: ectopic spleen, wandering spleen, splenosis, contrast-enhanced ultrasonography, contrast-enhanced ultrasound
Citation: Xiao M, Liang J, Ren J, Zheng R and Wu L (2024) The imaging features of ectopic spleen: which modality is more consistent? A cases series report and literature reviews. Front. Oncol. 14:1310394. doi: 10.3389/fonc.2024.1310394
Received: 09 October 2023; Accepted: 20 February 2024;
Published: 11 March 2024.
Edited by:
David Aebisher, University of Rzeszow, PolandReviewed by:
Jad Ahmad Degheili, Children’s Hospital of Eastern Ontario (CHEO), CanadaFatih Akbiyik, Yuksek Ihtisas University, Türkiye
Copyright © 2024 Xiao, Liang, Ren, Zheng and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lili Wu, d3VsbGlAbWFpbC5zeXN1LmVkdS5jbg==